EHRA Premium Access

Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS)

Event: EHRA 2019
Topic: Oral Anticoagulation
Session type: Satellite Symposium
Sponsored by BMS/Pfizer Alliance
Date: 18 March 2019
Time: 12:45 - 13:45

Congress Session

4 presentations in this session

NOACs for stroke prevention: achievements to date and impact on AF patient outcomes.

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

AF patients with ACS: the evolving landscape.

Speaker: Professor R. Storey (Sheffield, GB)
Thumbnail

AF patients with ACS: recent insights from AUGUSTUS and other trials.

Speaker: Professor R. Lopes (Durham, US)
Thumbnail

Panel discussion / Q&A - Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS).

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

4 speakers from this session

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20 presentations
0 follower

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

This platform is supported by

logo Novo Nordisk